 TEL AVIV, Israel and BETHESDA, Maryland, Aug. 4, 2021 PRNewswire -- Cannabics Pharmaceuticals Inc. OTCQB: CNBX, a global leader in the development of cancer related cannabinoid-based medicine, announced today that Prof. Caroline Robert MD. 